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a b s t r a c t
Beauvericin (BEA) is a bioactive compound produced by the secondary metabolism of several Fusarium
strains and is known to have various biological activities.
This study investigated the bioaccessibility of the BEA tested in concentrations of 5 and 25 mg/L, in a
model solution and in wheat crispy breads elaborated with different natural binding compounds as the
soluble alimentary dietary ﬁbers b-1,3 glucan, chitosan low molecular weight (L.M.W.), chitosan medium
molecular weight (M.M.W.), fructooligosaccharides (FOS), galattomannan, inulin and pectin, added at
concentrations of 1% and 5%. The bioaccessibility was determinated by employing a simulated gastroin-
testinal digestion that simulates the physiologic conditions of the digestive tract until the colonic com-
partment. The determination of BEA in the intestinal ﬂuids was carried out by liquid chromatography–
mass spectrometry detection (LC–MS). The mean BEA bioaccessibility data in the model solutions ranged
from 31.8% of the samples treated with only the duodenal digestion until 54.0% of the samples processed
including the colonic fermentation, whereas in the alimentary system composed by the wheat crispy
breads produced with different ﬁber concentration the duodenal and the duodenal + colonic BEA bioac-
cessibility resulted in 1.9% and 27.0% respectively.
 2012 Elsevier Ltd. All rights reserved.
1. Introduction
Beauvericin (BEA) is a cyclic hexadepsipeptide consisting of an
alternating sequence of three D-a-hydroxy-isovaleryl and three N-
methyl-L-phenylalanyl groups. It was originally isolated from Beau-
veria bassiana (Hamill et al., 1969) and has been detected since
then in various fungal species, including Fusarium spp., a common
contaminant of cereals and products composed by cereals (Jestoi,
2008).
The potential toxic role of BEA is exempliﬁed by results from
in vitro studies using cell lines. For instance, BEA induces signiﬁcant
cell deaths in insect, murine, and human tumor cell lines (Caló et al.,
2004; Jow et al., 2004; Fornelli et al., 2004; Ferrer et al., 2009;
Dornetshuber et al., 2009). Furthermore, BEA is a potent and speciﬁc
cholesterol acyltransferase inhibitor in rat liver microsomes
(Tomoda et al., 1992). In mammalian cell lines, cell deaths caused
by BEA have been suggested to involve a Ca2+ dependent pathway,
in which BEA induces a signiﬁcant increase in intracellular Ca2+
concentration that leads to cell death as a result of a combination
of both apoptosis and necrosis (Jow et al., 2004; Lin et al., 2005).
BEA has also been found as a natural contaminant of maize from
Poland, Italy, USA, South Africa, Switzerland and Slovakia; feed
samples from USA; rye from Finland; and oats, wheat and barley
from Norway and Finland (Jestoi, 2008). Logrieco et al. (1993) re-
ported high levels of BEA up to 60 mg/kg in maize from Poland,
while Ritieni et al. (1997) reported high levels of BEA up to
520 mg/kg in maize from Italy. Recently, Meca et al. (2010b) have
reported the contamination of cereals available in the Spanish mar-
ket with BEA and levels ranged from 0.51 to 11.78 mg/kg.
In the analysis of the risk evaluation related to the human
health, food ingestion is considered to be one of the important
routes of exposure of many contaminants (Carolien et al., 2005).
To achieve any effect in a speciﬁc tissue or organ, the mycotox-
ins must be available, which refers to the compound’s tendency to
be extracted from the food matrix, and they must then be absorbed
from the gut via the intestinal cells (Fernández-García et al., 2009).
The term bioaccessibility has been deﬁned as the fraction of a
bioactive compound present in a food matrix that passes unmodi-
ﬁed complex of the biochemical reactions relationated to the gas-
trointestinal digestion and thus becomes available for intestinal
absorption (Fernández-García et al., 2009).
Studies on animals and humans show that oral bioaccessibility
of some bioactive compounds present in food can be signiﬁcatively
modiﬁed depending on the food source. Nowadays, there is no data
in the literature regarding the bioaccessibility of the minor Fusar-
ium mycotoxin BEA, but the study of the bioaccessibility of other
mycotoxins has been evaluated by many authors. In particular,
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Avantaggiato et al. (2003, 2004) studied the bioaccessibility of zea-
ralenone (ZEA), fumonisin B1 (FB1), fumonisin B2 (FB2), ochratoxin
A (OTA), deoxynivalenol (DON) and aﬂatoxin B1 (AFB1) present in
feed enriched with adsorbent materials, as activated carbons and
others, that have the properties to adsorb the mycotoxins, and so
reduce the presence of these compounds in the gastrointestinal
tract, utilizing a laboratory system that simulated the metabolic
processes of the gastrointestinal tract of healthy pigs.
In addition, Avantaggiato et al. (2007) evaluated the inﬂuence of
the carbon/aluminosilicate based product added in the production
of feeds, on the reduction of the bioaccessibility of FB1, FB2, OTA,
DON and ZEA, demonstrating that the employment of the adsor-
bent materials can prevent the individual and combined adverse
effects of some Fusarium mycotoxins in animals.
Motta and Scott (2009) studied the percentage of total bound
fumonisin B1 (TB-FB1), formed for the reaction of the FB1 with
some components present in food as amino acids or sugars, in corn
ﬂakes applying an in vitro gastro-digestion model.
As demonstrated by the studies previously mentioned, the
employment of the adsorbent materials in the technology of the
production of feeds has the property to reduce the exposure risk
to the Fusarium mycotoxins in animals fed with these bioactive
feeds. These typologies of capturing mycotoxin materials are thus
applicable to the animal nutrition, but, in nature, there are prod-
ucts that are capable of capturing some toxic components present
in food, like the alimentary ﬁber.
According to the American Association of Cereal Chemists
(AACC), dietary ﬁber is deﬁned as the edible part of plants or anal-
ogous carbohydrates that are resistant to digestion and absorption
in the human small intestine with complete or partial fermentation
in the large intestine (Nair et al., 2010).
Dietary ﬁbers may be classiﬁed as water-soluble ﬁbers, that are
represented principally by pectins, b-glucans, glucomannans, fruc-
tooligosaccharides (FOS), galactooligosaccharides (GOT), and inu-
lin, and water insoluble ﬁbers represented mainly by cellulose,
lignin, and hemicelluloses present mainly in wheat, most grain
products, and vegetables (Nair et al., 2010). In particular, the solu-
ble ﬁbers are important for several biological and technological
activities such as: prebiotic, glycemic index reducers, fat, protein
and carbohydrate replacers, reducer in cholesterol and triglycer-
ides absorption, etc. (Min et al., 2010; Cugnet-Anceau et al.,
2010;Pereira et al., 2010; Nair et al., 2010; Rodrigues et al.,
2011). There are only two publications relating mycotoxins to
the dietary ﬁber, which are the studies by Meissonnier et al.
(2009) and Rabassa et al. (2010). The ﬁrst one demonstrated that
the supplementation of an animal diet with glucomannan protects
the same against immunotoxicity caused by AFB1, and T-2 toxin
during a vaccinal protocol. Rabassa et al. (2010) reported that the
dietary ﬁber glucomannan added as sorbent material in a rumi-
nant’s diet, reduced possible liver aggression caused by AFB1.
Considering all these aspects, the aimof the studywas to evaluate
different solubleﬁbers suchasb-1,3glucan, chitosan lowM.W., chito-
sanmediumM.W., fructooligosaccharides (FOS), galattomannan, inu-
lin and pectin used as sorbent material, that inﬂuence the duodenal
and colonic bioaccessibility in vitro of theminor Fusariummycotoxin
BEA: (a) inmodel solutions composedbyaqueous solutionsof eachﬁ-
ber (1% and 5% (w/v)) contaminatedwith 5 and 25 mg/L of BEA, (b) in
cookedcrispybreadspreparedwith1%and5% (w/w)of eachﬁber and
contaminated with 5 and 25 mg/kg of BEA.
2. Materials and methods
2.1. Materials
Potassium chloride (KCl), potassium thiocyanate (KSCN), monosodium phos-
phate (NaH2PO4), sodium sulfate (NaSO4), sodium chloride (NaCl), sodium bicar-
bonate (NaHCO3), urea, a-amylase, hydrochloric acid (HCl), sodium hydroxide
(NaOH), formic acid, pepsin, pancreatin, bile salts, phosphate buffer saline (PBS,
pH 7.5), b-1,3 glucan, chitosan low M.W., chitosan medium M.W., fructooligosac-
charides (FOS), galattomannan, inulin and pectin were obtained from Sigma–Al-
drich (Madrid, Spain). Acetonitrile, methanol and ethyl acetate were purchased
from Fisher Scientiﬁc (Madrid, Spain). Deionized water (<18 MX cm resistivity)
was obtained from a Milli-Q water puriﬁcation system (Millipore, Bedford, MA,
USA). Chromatographic solvents and water were degassed for 20 min using a Bran-
son 5200 (Branson Ultrasonic Corp., CT, USA) ultrasonic bath.
The BEA employed/utilized in this study were produced and puriﬁed according
to the method of Meca et al. (2010a).
2.2. Model solution preparation
The model solutions were prepared in 100 mL Erlenmeyers, suspending 1 and
5 g of each soluble alimentary ﬁber (b-1,3 glucan, chitosan lowM.W., chitosan med-
ium M.W., (FOS, galattomannan, inulin and pectin) in 100 mL of distilled water, to
obtain solutions at 1% and 5% (w/v) of each ﬁber. The solutions were mixed using
ultrasound bath (Lab Police, Barcelona, Spain) operating at a temperature of
30 C, and then 10 mL from each solution was contaminated with 5 mg BEA/L,
and other 10 mL with 25 mg BEA/L. The contamination of the solutions was carried
out using a stock methanolic solution (1000 mg/L) of BEA.
The solutions were digested with a simulated gastrointestinal digestion to as-
sess the bioaccessibility of the BEA.
2.3. Wheat crispy breads production
For the production of the wheat crispy breads with different ﬁber concentra-
tions, 300 g of wheat ﬂour, 3 g of sucrose, and 6 g of NaCl, were mixed with 3.0
and 15.4 g of each dietary ﬁber (b-1,3 glucan, chitosan low M.W., chitosan medium
M.W., (FOS, galattomannan, inulin and pectin) to obtain dough with 1% and 5% (w/
w) of each prebiotic compound employed. These mixtures were then mixed with
180 mL of water during 5 min. No fermentation was done. The dough, divided in
the shape of small round breads, was treated at 220 C during 20 min.
2.4. Bacterial strains and growth conditions
Thirteen commercial probiotic strains were obtained for the in vitro system
that simulates the physiologic condition of the colonic intestinal compartment.
In particular Lactobacillus animalis CECT 4060T, L. casei CECT 4180, L. casei
rhamnosus CECT 278T, L. plantarum CECT 220, L. rhuminis CECT 4061T, L. casei
casei CECT 277, Biﬁdobacterium breve CECT 4839T, B. adolescentes CECT 5781T
and B. biﬁdum CECT 870T, Corynebacterium vitaeruminis CECT 537, Streptococcus
faecalis CECT 407, Eubacterium crispatus CECT 4840, Saccharomyces cerevisiae CECT
1324 were obtained at the Spanish Type Culture Collection (CECT Valencia,
Spain), in sterile 18% glycerol.
For longer survival and higher quantitative retrieval of the cultures, they were
stored at 80 C. When needed, recovery of strains was undertaken by two consec-
utive subcultures in appropriate media prior to use (Laparra and Sanz, 2009; Meca
et al., 2012a).
2.5. In vitro digestion model
The procedure was adapted from the method outlined by Gil-Izquierdo et al.
(2002), with slight modiﬁcations. The method consists of three sequential steps;
an initial saliva/pepsin/HCl digestion for 2 h at 37 C, to simulate the mouth and
the gastric conditions, followed by a digestion with bile salts/pancreatin for 2 h at
37 C to simulate duodenal digestion (Fig. 1). The colonic conditions were simulated
adding to the duodenal simulated ﬂuid some bacteria representative of the gastro-
intestinal tract.
For the saliva/pepsin/HCl digestion, 10 mL of the model solution or 10 g of the
crispy bread contaminated with 5 and 25 mg/kg of BEA, were mixed with 6 mL of
artiﬁcial saliva composed by: KCl 89.6 g/L, KSCN 20 g/L, NaH2PO4 88.8 g/L, NaSO4
57 g/L, NaCl 175.3 g/L, NaHCO3 84.7 g/L, urea 25 g/L, 290 mg of a-amylase. The
pH of this solution was corrected at 6.8 with NaOH 0.1 N.
These mixtures composed by model solutions and by the artiﬁcial saliva were
placed in plastic bags, containing 40 mL of water and homogenized by Stomacher
IUL Instruments (Barcelona, Spain) during 30 s.
To this mixture, 0.5 g of pepsin (14,800 U) dissolved in 25 mL of HCl 0.1 N was
added. The pH of the mixture was corrected to a value of 2 with HCl 6 N, and then
incubated in a 37 C orbital shaker (250 rpm) (Infors AG CH-4103, Bottmingen,
Switzerland) for 2 h.
After the gastric digestion, the pancreatic digestion was simulated. The pH was
increased to 6.5 with NaHCO3 (0.5 N) and then 5 mL of (1:1; v/v) pancreatin (8 mg/
mL):bile salts (50 mg/mL), dissolved in 20 mL of water, was added and incubated in
a 37 C orbital shaker (250 rpm) for 2 h. An aliquot of 5 mL of the duodenal simu-
lated ﬂuid was sampled for the extraction of the BEA and the determination of
the duodenal bioaccessibility.
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Fig. 1. Schematic representation of the in vitro digestion model. The in vitro digestion model describes a four-step procedure simulating the digestive processes, considering
the mouth, stomach, small and large intestines. In each compartment, the matrix was incubated at 37 C and the pH was modiﬁed according to the physiologic conditions.
This procedure permits to simulate in vitro the physiologic condition of the human gastrointestinal tract and to study how some components present in the diet can inﬂuence
the bioaccessibility of the bioactive compounds.
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Fig. 2. LC–MS/MS chromatogram of the minor Fusarium mycotoxins BEA present in the bioaccessible fraction were obtained applying a simulated gastrointestinal digestion
model to a crispy bread sample produced with 5% of the dietary ﬁber inulin and contaminated with 5 mg/kg of the bioactive compound.
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To simulate the colonic compartment Bacterial strains (previously described)
were grown in a sterile plastic centrifuge tube overnight at 37 C in MRS broth (Ox-
oid, Madrid, Spain) under anaerobic conditions (5% CO2/95% air). Then, the tubes
were centrifuged at 4000 rpm during 5 min. at 23 C and the bacteria were resus-
pended in sterile PBS. A 500 lL of a mixture of the bacterial suspensions at concen-
trations of 1014 CFU/mL was added to duodenal simulate intestinal ﬂuid and
incubated at 37 C in 5% CO2/95% air 48 (Laparra and Sanz, 2009).
After this last digestion, 5 mL of the mixture was centrifugated at 4000 rpm
during 10 min at 4 C, and extracted for BEA determination and for the estimation
of the duodenal + colonic bioavailability.
2.6. BEA extraction from the simulated intestinal ﬂuids
BEA contained in the duodenal and duodenal + colonic ﬂuids were extracted as
follows. Five milliliters of each mixture previously described were placed in a 20 mL
test tube, and extracted three times with 5 mL of ethyl acetate using a vortex VWR
international (Barcelona, Spain) for 1 min. Then, the mixtures were centrifugated
(Centrifuge 5810R, Eppendorf, Germany) at 4000 rpm and at 4 C for 10 min. The
organic phases were completely evaporated by a rotary evaporator (Buchi,
Switzerland) operating at 30 C and 30 mbar pressure, resuspended in 1 mL of
methanol and ﬁltered with a 0.22 lM ﬁlter (Phenomenex, Madrid, Spain) before
being analyzed by LC–MS/MS.
2.7. BEA analysis
The separation of BEA was achieved by an Agilent 1100 (Agilent Technologies,
Santa Clara, California) LC coupled to an Applied Biosystems/MDS SCIEX Q TRAP
TM linear ion trap mass spectrometer (Concord, Ontario, Canada). A Gemini
(150  2.0 mm, 5 lm) Phenomenex (Torrance, California) column was used. LC con-
ditions were set up using a constant ﬂow at 0.2 mL/min and acetonitrile:water
(70:30, (v/v) with 0.1% of HCOOH) as mobile phase in isocratic condition was used.
The instrument was conﬁgured in the positive ion electrospray mode using the fol-
lowing parameters: cone voltage 40 V, capillary voltage 3.80 kV, source tempera-
ture 350 C, desolvation temperature 270 C and collision gas energy 5 eV.
Multiple reaction monitoring (MRM) technique was used for identiﬁcation and
quantiﬁcation, in which protonated molecule [M+H]+ of the BEA m/z 784.50, was
fragmented in the collision cell to the product-ion m/z 244.20. For quantiﬁcation,
the product-ion m/z 244.20 was used (Jestoi et al., 2009).
2.8. Calculations and statistical analysis
All experiments were performed by triplicate. Statistical analysis was carried
out using the analysis of variance (ANOVA), followed by Dunnet’s multiple compar-
ison tests. Differences were considered signiﬁcant if p < 0.05.
3. Results and discussion
It is now well established that the colonic microﬂora has a pro-
found inﬂuence on health (Steer et al., 2000). Consequently, there
is currently a great deal of interest in the use of prebiotics as func-
tional food ingredients to manipulate the composition of colonic
microﬂora in order to improve health (Wang, 2009).
Thus, prebiotics, such as oligosaccharides, are deﬁned as ‘‘non-
digestible food ingredient(s) that beneﬁcially affect host health
by selectively stimulating the growth and/or activity of one or a
limited number of bacteria in the colon’’ (Gibson and Roberfroid,
1995). This deﬁnition was updated in 2004 and probiotics are
now deﬁned as ‘‘selectively fermented ingredients that allow spe-
ciﬁc changes, both in the composition and/or activity in the gastro-
intestinal microbiota that confers beneﬁts upon host well-being
and health’’ (Gibson et al., 2004).
Prebiotics show both important technological characteristics
and interesting nutritional properties (Huebner et al., 2007). Sev-
eral of them are found in vegetables and fruits and can be industri-
ally processed from renewable materials. In food formulations,
they can signiﬁcantly improve organoleptic characteristics,
upgrading both taste and mouth feel. In order to be used as func-
tional food ingredients, prebiotics must be chemically stable to
food processing treatments, such as heat, low pH, and Maillard
reaction conditions.
Some probiotic compounds have also the property to capture
some bioactive compounds present in food as polyphenols, and
after the hydrolysis of their structure by the enzymes complex of
the bacteria present in the intestinal colonic compartment, they
can interact with the intestinal epithelium, be absorbed and act
on the different organs and tissues of the human body.
The object of this study was to evaluate if some soluble alimen-
tary ﬁbers can interact with the minor Fusarium mycotoxin BEA,
reducing the bioaccessibility of this bioactive compound, in a mod-
el solution and in a food model composed by a wheat crispy bread
produced with two percentages of the prebiotics (1% and 5%), and
spiked with 5 and 25 mg BEA/L.
As is possible to observe in the Fig. 3a, the duodenal bioaccessi-
bility (%) of the BEA present in the model solution produced with-
out the ﬁbers (control) at the two concentrations tested was of
92.6 ± 1.2 and 90 ± 1.3, respectively for 5 and 25 mg BEA/L. How-
ever, when the soluble alimentary ﬁbers are added to the model
solutions a great reduction of BEA bioaccessibility was obtained
at the two concentrations employed. In particular, at the concen-
tration of 5 mg/L, the mean bioaccessibility datum was 13.2%.
The lowest reduction of BEA bioaccessibility was evidenced by
the ﬁber FOS (5%), with 21.5 ± 1.4%. At the concentration of
25 mg/L, the mean bioaccessibility of the bioactive compound em-
ployed was 50.4%. The highest bioaccessibility reduction of BEA
was evidenced by the dietary ﬁber galattomannan that in the mod-
el solution evidenced only the 10.8 ± 0.9%, whereas the lowest
reduction was evidenced by the ﬁber FOS (1%) with 85.0 ± 2.3%.
Another ﬁber that considerably reduced BEA bioaccessibility is inu-
lin, which, used in the concentration of 5%, showed a BEA bioacces-
sibility of only 2.6 ± 0.5%.
When the model solutions were digested with the duodenal and
colonic digestions, the data obtained are completely different. In
particular, as it is shown in Fig. 3b, the BEA bioaccessibility in-
creases in all the assays carried out. The mean values reported at
5 and 25 mg/L were 36.6 and 69.8%, respectively. The same ﬁbers,
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Fig. 3. Bioaccessibility evidenced by the BEA in the model solutions constituted of
water suspensions containing different soluble dietary ﬁbers contaminated with 5
(black square) and 25 mg/kg (white square) of the minor Fusarium mycotoxin (a)
until duodenal digestion and (b) duodenal + colonic digestion.
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that evidenced a good BEA capture action in the model solution di-
gested only with the duodenal compartment, can complex effec-
tively the mycotoxin using sequentially the duodenal and the
colonic simulated gastrointestinal digestions as well.
BEA bioaccessibility ranged from 1.3 to 38-fold higher than the
data reported using only the duodenal digestion. This difference
can be related to the fermentation of the ﬁbers carried out by the
bacteria employed.
Regarding the experiments performed with the food system
composed by wheat crispy bread produced with the prebiotic com-
pounds and contaminated with 5 and 25 mg/L of BEA, the results
are reported in the Fig. 4a and b. The mean bioaccessibility data
of the bioactive compounds tested at the two concentrations (5
and 25 mg BEA/L) were of 2.4% and 1.5% respectively. All the pre-
biotic compounds tested reduced the bioaccessibility of the BEA,
and in particular the reduction evidenced ranged from 96% to
99% considering the two concentrations employed. These data
demonstrated that, considering only the duodenal intestinal com-
partment, the alimentary matrix enriched with ﬁbers has the prop-
erty to capture BEA, thus reducing its bioaccessibility. A LC–MS/MS
chromatogram of BEA present in the bioaccessible fraction ob-
tained applying the simulated gastrointestinal digestion model to
a crispy bread sample produced with 5% of the dietary ﬁber inulin
and contaminated with 5 mg/kg of the bioactive compound is plot-
ted in the Fig. 2.
The results obtained when the crispy breads were digested
using the complete gastrointestinal model (included the colon
compartment) are very different. In these experiments, due to
the action of the fermentation operated by the probiotic strains,
the ﬁbers were hydrolyzed, increasing the BEA concentration in
the colonic simulated intestinal ﬂuid and then incrementing its
bioaccessibility.
The mean bioaccessibility values of the mycotoxin obtained at
the two concentrations used were of 12.9% and 42.4% respectively,
5.3 and 28.2-fold higher than the data evidenced with the sample
treated only with the duodenal digestion. The highest bioaccessi-
bility data at 5 mg/L, was evidenced by the dietary ﬁber FOS,
whereas at 25 mg/L by inulin, with 37.9 ± 1.3% and 79.5 ± 2.2%,
respectively. This phenomenon is probably due to the high capac-
ity of the microbial enzymes to degrade the fructooligosaccharides
as FOS and inulin, with respect to other alimentary ﬁbers. The
highest bioaccessibility reductions were obtained by the chitosan
low M.W., with 7.0%, and by the b-1,3 glucan with 16.6%, at the
BEA concentrations of 5 and 25 mg/L respectively. These two ali-
mentary ﬁbers, used nowadays in nutraceutical products, have
the capacity to resist the fermentation operated by bacteria, reduc-
ing the bioaccessibility of the bioactive compounds captured.
The data evidenced in this study demonstrate that some prebi-
otic compounds help to reduce the risk associated with the intake
of the minor Fusarium mycotoxin BEA, with a mechanism of reten-
tion for this compound similar to the phenomenon already evi-
denced for the polyphenols.
In addition, this study demonstrates that the binding capacity of
the bioactive compound BEA to the soluble ﬁbers employed is
higher when BEA was used in the lowest concentration (5 mg/L).
This phenomenon can probably be related to the presence of re-
stricted active binding sites in the ﬁbers that prevent the binding
of toxic compounds to the highest concentration as previously
demonstrated by Ta et al. (1999) and Zhang et al. (2011) for other
types of contaminants.
Comparing the reduction of BEA bioaccessibility in the model
solution vs the crispy bread, the results obtained were clearly dif-
ferent. Considering only the duodenal bioaccessibility at 5 and
25 ppm concentrations, the bioaccessibility evidenced in the ali-
mentary system composed by wheat crispy bread was 5.3 and
33.3-fold lower than the one in the model solutions. Considering
the duodenal + colonic bioaccessibility, no signiﬁcant differences
were detected at 5 ppm concentration whereas at 25 ppm, the bio-
accessibility detected in the food system resulted 5.4-fold lower
than the data obtained in the model solution. In the experiments
carried out using the alimentary system, there is a considerable de-
crease of BEA bioaccessibility compared to the model solution. This
phenomenon can be related to the food composition. In particular,
the mycotoxins that are spiked in food or that naturally contami-
nate the food are complexed to the food matrix. The formation of
this complex is dependent on the amount of the micro and
macronutrients contained in the food, such as ﬁbers, sugars, pro-
teins, minerals, etc. (Kabak et al., 2009). Different bioavailability
values were also reported by several authors (Carolien et al.,
2005), comparing the bioavailability of the same compounds con-
tained in liquid or solid food (Meca et al., 2012b).
In the scientiﬁc literature there is no data regarding the reduc-
tion of the bioaccessibility of the minor Fusariummycotoxin BEA in
food by employing prebiotics as soluble alimentary ﬁber com-
pounds as adsorbent materials, and few studies have been pub-
lished on the employment of inulin in feed in order to reduce the
toxic effects of the trichothecenes on different organs of several
animals.
In particular Meissonnier et al. (2009) investigated how the die-
tary supplements with yeast-derived glucomannan protected pigs
against the deleterious effects by the exposure to AFB1 or T-2 toxin.
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Fig. 4. Bioaccessibility evidenced by BEA in the alimentary system constituted of
wheat crispy breads produced with 1 and 5% of each soluble alimentary ﬁbers and
contaminated with 5 (black square) and 25 mg/kg (white square) of the minor
Fusarium mycotoxin (a) until duodenal digestion and (b) duodenal + colonic
digestion.
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Three doses of pure mycotoxin (AFB1 trial: 482, 968 and 1912 lg/
kg feed; T-2 toxin trial: 593, 1155 and 2067 lg/kg feed) with or
without dietary glucomannan supplementation (2 g/kg feed) were
tested in weaned pigs for 28 days. In the AFB1 trial glucomannan
decreased the severity of liver lesions in animals exposed to
968 lg/kg feed. Exposure to both AFB1 and T-2 toxin were associ-
ated with impaired phase I liver enzyme activities, but glucoman-
nan demonstrated a limited protective effect on these enzymes.
Glucomannan supplementation restored the ovalbumin-speciﬁc
lymphocyte proliferation that was delayed in pigs exposed to
AFB1, regardless of dose. In the T-2 toxin trial glucomannan supple-
mentation restored anti-ovalbumin immunoglobulin G production,
which was signiﬁcantly reduced in pigs exposed to both medium
and high doses of the toxin. The authors demonstrated that gluco-
mannan dietary supplementation demonstrated no deleterious ef-
fects in control animals and protective effects against AFB1 and T-2
toxin immunotoxicity during a vaccinal protocol.
Awad et al. (2009) studied the inﬂuence in feed for chicken
nutrition, of a probiotic strain as Eubacterium sp. and of a prebiotic
as the inulin, in the reduction of the injuries of the gastrointestinal
tract induced by the mycotoxin DON. The authors demonstrated
that the alteration caused by DON was reduced by supplementing
the Don containing diets with probiotic feed additive. In the pres-
ence of the acute toxicity of DON, the dietary inulin supplementa-
tion may be useful in reducing the toxic effects of DON on
intestinal glucose transport. This indicates that in the case of
DON contamination of feedstuffs the addition of feed additive
would be a proper way to counteract the possible impacts due to
this mycotoxin.
Rabassa et al. (2010) studied the inﬂuence of the sorbent mod-
iﬁed glucomannan on metabolic parameters of sheep submitted to
diets containing AFB1 and ZEA. For this, 34 females were used and
they were divided into six groups, receiving 1.0 mg/kg of ZEA,
1.5 mg/kg of AFB1 and/or 2 kg/ton of sorbent. From the analysis
of the results it resulted that ZEA caused metabolic alterations in
sheep, and the modiﬁed glucomannan was effective in reducing
the possible liver aggression caused by this mycotoxin, shown by
the decrease in the levels of AST.
Nowadays, the study of the bioaccessibility of other mycotoxins
in the presence or not of binding material used in animal nutrition
has been evaluated by many authors.
In particular, Avantaggiato et al. (2003) studied the intestinal
absorption of ZEA by using a laboratory model that simulated the
physiology of the gastrointestinal tract of healthy pigs. Approxi-
mately 32% of ZEA was released from the food matrix to the bioac-
cessible fraction during 6 h of digestion and was rapidly absorbed
at the intestinal level.
Avantaggiato et al. (2004), studied an in vitro screening of 14
adsorbent materials, including some commercial products used
to detoxify Fusarium-mycotoxins, were tested in the pH range of
3–8 for DON and nivalenol (NIV)-binding ability. A dynamic labo-
ratory model simulating the gastrointestinal (GI) tract of healthy
pigs (TIM system) was used to evaluate the small-intestinal
absorption of DON and NIV and the efﬁcacy of activated carbon
in reducing the relevant absorption. The invitro intestinal absorp-
tions of DON and NIV were 51% and 21%, respectively, as referred
to 170 mg DON and 230 mg NIV ingested through contaminated
(spiked) wheat. Most absorption occurred in the jejunal compart-
ment for both mycotoxins. The inclusion of activated carbon pro-
duced a signiﬁcant reduction in the intestinal mycotoxin
absorption. The binding activity of activated carbon for these tri-
chothecenes was lower than that observed for zearalenone, a
mycotoxin frequently co-occurring with them in naturally contam-
inated cereals.
In 2005, Carolien et al. described the applicability of an in vitro
digestion model to study the bioaccessibility of the AFB1 from
peanut slurry and of the OTA from buckwheat, evidencing bioac-
cessibility data of 94% and 100%, respectively.
Recently, Kabak et al. (2009), studied the bioaccessibility of the
AFB1 in pistachio nuts, buckwheat, and in infant foods using an
in vitro model under fed condition. The average bioaccessibility
of AFB1 and OTA was about 90%, and 30%, respectively, depending
on several factors, such as food product, contamination level,
compound and type of contamination (spiked vs. naturally
contaminated).
Marroquın-Cardona et al. (2009) evaluated twelve different
additives distributed in Mexico as mycotoxin (AFB1) binders in
feed utilizing: Ca-montmorillonite, Na-montmorillonite, alumino-
silicates, organo-aluminosilicates, glucomannan/b-D-glucan con-
taining yeast product and a synergistic mixture of minerals,
biological constituents, including enzymes and BBSH microbe,
plant-derived extracts such as ﬂavonolignans, saponins and terpe-
noids, and some algae materials, as mycotoxin binders. The exper-
iment adsorptions were conducted at pH 2 and pH 6.5, mimicking
pH conditions in the stomach and small intestine. The results ob-
tained by the authors demonstrated that adding the binder to
the feed preparation the reaction of the AFB1 in the alimentary
preparation digested was reduced from 50% to the 95%, depending
on the additive utilized.
4. Conclusion
This is the ﬁrst time that the bioaccessibility of the Fusarium
mycotoxin BEA in the presence of some alimentary soluble ﬁbers
was investigated using a system that simulates the physiologic
conditions of the gastrointestinal tract. In the experiments carried
out employing the model solutions contaminated with 5 and
25 mg/L of BEA and containing 1% and 5% of each dietary ﬁber
the highest reduction of BEA bioaccessibility was evidenced in
the experiments carried out with the ﬁbers galattomannan obtain-
ing a mean BEA bioaccessibility data of 5.2%. In the experiments
carried out simulating an alimentary system composed of wheat
crispy bread, the more efﬁcient ﬁbers that reduced BEA bioaccessi-
bility were chitosan MMW and the galattomannan.
In conclusion the ﬁbers used resulted in binding the bioactive
compound tested until the treatment with the colonic bacteria that
hydrolyze the prebiotic compounds increasing partially the bioac-
cessibility of the mycotoxin. The results help to explain as some
natural components present in the food can help to modulate the
intake of some toxic compounds.
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